When growth gets a seat on the executive committee
What changes when a growth leader is asked for a number instead of a campaign: capital discipline, cross-functional trade-offs and a new relationship with unit heads.
What changes when a growth leader is asked for a number instead of a campaign: capital discipline, cross-functional trade-offs and a new relationship with unit heads.
Catchment, referred and institutional demand need different owners, metrics and investment logic, and forcing them through one funnel hides which one is failing.
Where growth and clinical governance collide in a hospital group, what a working partnership with the medical director looks like, and the lines growth must never cross.
Corporate empanelment, referral networks, international facilitators and TPA desks are a sales function; how to structure, measure and keep it ethical.
Scheme tariffs, TPA floors, packages, cash patients and front-desk discounting: where a hospital growth leader can actually move price and where it is pretending.
The eight parts of hospital revenue, which ones marketing actually controls, and what it takes to be accountable for the whole line rather than a slice.
Capital ask, gestation, shared costs, cannibalisation and a vertical head with full P&L: the conversation an executive committee has before the deck is opened.
Why hospital innovation teams drift into showcases, the stage-gates that keep them honest, what a real innovation budget looks like, and how to kill a project cleanly.
A reading order for the hospital management pack: occupancy against yield, payer and specialty mix, OPD conversion, receivables, discounts, and the lags that reveal old decisions.
Which new delivery formats add margin to a hospital group, which add volume without margin, and which exist to protect the core, judged on unit economics.